Tag: BioChaperone
ADOCIA announces the positive results of a Phase 1 study on BioChaperone® Lispro with its partner Tonghua Dongbao – 2022-12-29 at 08:00
• Adocia’s partner, Tonghua Dongbao, announced that the primary endpoint of this Phase 1 study has been met and that the results confirmed an accelerated profile of BioChaperone® Lispro compared…
Adocia announces the positive results of a study on BioChaperone Lispro – 29/12/2022 at 08:38
(AOF) – Adocia, a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, today announces new positive…
Adocia: start of a study for BioChaperone Combo
(CercleFinance.com) – Adocia climbs 6% after the announcement by the biopharmaceutical company of a first subject treated with BioChaperone Combo in the CT046 clinical trial, one of three studies funded…
ADOCIA announces the dosage of the first patient in the Phase 3 program of BioChaperone® Lispro with its partner Tonghua Dongbao – 05/09/2022 at 09:00
• A first patient has been dosed as part of this large phase 3 program involving 1,300 people with type 1 or 2 diabetes in 100 clinical research centers in…